Minerva Neurosciences | Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Adma Biologics USD 70.08M 3.32M 2025-09
ALKERMES USD 285.82M 639K 2024-09
Alterity Therapeutics Limited AUD 103.21K 73.88K 2023-06
AstraZeneca USD 6.55B 19.43B 2025-09
BioCryst Pharmaceuticals USD 194.37M 48.43M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.69B 1.37B 2025-06
Dynavax Technologies USD 220.97M 214K 2025-09
Eli Lilly USD 40.87B 6.69B 2025-09
Esperion Therapeutics USD 262.48M 235.95M 2024-06
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 10.67B 564.4M 2025-09
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
J&J USD 39.41B 173M 2025-09
Merck USD 39.97B 6B 2025-09
Minerva Neurosciences USD 0 86.58M 2024-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 24.24B 174M 2025-09
Novavax USD 223.63M 187K 2024-09
Pfizer USD 57.41B 93M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Takeda JPY 4.27T 81.29B 2025-12
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12


Minerva Neurosciences Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.